Advances in Transfusion Medicine Bellwether for Lucrative Strides in Immunohematology

The growing focus of the quality of safety of blood products, especially in pre-transfusion, has helped the immunohematology market grow substantially over the past few years. Large strides in the market have been enabled as well as accelerated by advancing biology of blood transfusion. Further, advances in transplant biology are opening new avenues in the immunohematology market. Developed as well developing regions have been continuously adopting automation in their testing techniques.

Get Sample Copy of this Report @ 

https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1214

Advances in Hemagglutination Spur Deployment of Automated Equipment

Major equipment manufacturers in the immunohematology market world over have garnered sizable opportunities due to adoption of automated equipment in immunohematology in developing economies. In general, the growing trend of automation has spurred new avenues in the market. In this regard, advances in hemagglutination techniques have helped supplement the strides. Techniques such as column agglutination methods and magnetized erythrocyte technology have paved way to faster deployment of automation solutions.

Strides made in laboratory technologies and their use in transfusion medicine are bellwether for new avenues in the immunohematology market. Both laboratory centered services and patient care services have seen new developments. Adoption of new anticoagulant preservative solutions have further expanded the horizon for players in the market.

Multiple Antigen/Antibody Testing Platforms Expand Horizons

The immunohematology market has made major strides on the back of service providers adopting advanced molecular blood grouping. These techniques have helped overcome the limitations of serology that a few transfused patients who have undergone transfusion in recent years. Advent of high throughput technologies such as microarrays and mass spectrometry have helped blood banks meet new patients’ requirements. Moreover, multiple antigen/antibody testing platforms are poised to expand the horizon of transfusion medicine in the immunohematology market globally. Further, growing testing for transfusion transmitted infections has helped catalyze revenues in the market.

Check Table of Contents of this Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=1214

However, there still remains a few challenging areas for blood banks and proponents of transfusion medicine. One such area is maintaining rare donor registries. Technological advancements in apheresis are also instrumental in broadening the outlook of the market.

Immunohematology Market: Emergence of Improvised Blood Screening Techniques to Bode Well for Growth, finds TMR

Immunohematology, known as “blood banking” in common parlance, is predicted to see surging demand due to the emergence of better techniques for blood screening and launch of new products every now and then, finds a report by Transparency Market Research. The report, titled, “Immunohematology Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017–2025,” shows that savvy industry players are pouring money into research and development of improved products to grow their sales and revenues.

A noticeable trend in the market for immunohematology is the growing uptake of automated instrumentation and integration of various functions on to a single platform by hospitals and diagnostic laboratories. Such developments, along with mergers and acquisitions by players to create value and synergies, are also having a positive impact on the market. Apart from that, rising popularity of cord blood banking on account of the stem cell they contain, is serving to propel the market too. This is because the collected cord blood is preserved after carrying out various immunohematology tests.

Some of the main product segments in the global immunohematology market are immunohematology analyzers and immunohematology reagents. Application-wise, the market can be segmented into HIV, blood-related diseases, and hepatitis. Hospitals, diagnostic laboratories, ambulatory surgical centers, and blood banks are some of the key end use segments in the market.

From a geographical standpoint, North America is the key market for immunohematology because of the rising instances of blood-related diseases such as hepatitis and HIV and trauma. Increased awareness among people about the early treatment and continued thrust on product development are also serving to drive the market. Europe is another key market that has risen steadily on the back of effective and superior technologies.

Some of the prominent participants in the global market for immunohematology are Grifols, Bio-Rad Laboratories, Inc., Immucor, ThermoFisher, Hologic, Inc., Abbott, Beckman Coulter, Becton, Dickinson and Company and Roche Diagnostics, Inc.

Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=31544

Immunohematology Market Growth Helped by Advanced Technology

San Francisco, California, November 16, 2017: Immunohematology Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025 is the latest report added in the vast report repository of the TMR Research which talks about the global landscape of the immunohematology market for the given forecast period. The study report maps the global market for immunohematology in terms of the latest trends that are currently prevailing in the market, driving and restraining factors of the global market, and the possible opportunities that may arise in the market over the course of the given forecast period. The study report also provide an in-depth evaluation of the current dynamics of the global immunohematology market and talks about the overall competitive landscape of the market. The research report is the result of the data gathered through comprehensive assessment of the market and the information collected from the experts in the industry. The study report also provides crucial information on the prominent players that are presently plying their trade in the global immunohematology market. The report also cover the overall prospects of growth of the global market during the course of the mentioned forecast period of 2017 to 2025.

Immunohematology aids in assessing the Rh factor, white blood cells components, antigens, and plasma in the blood of the donor person. This procedure is commonly called as blood banking and deals with the readying up of the blood cells for the process of transfusions. Immunohematology aids in cutting down the risks associated with the transfusion of blood such as HIV and thalassemia.

The global market for immunohematology is projected to expand in a considerable manner over the coming years of the given forecast period. The research report has given out the key factors that are expected to drive the overall growth of the global market. One of the key factor responsible for driving the growth of the global immunohematology market is the emergence of novel and technologically advanced products in the market. In addition to this, the exponentially increasing rate of trauma cases across the world are also expected to a significant role in augmenting the development of the global immunohematology market.

However, there are some factors which are expected to impede the growth of the global market over the course of the given forecast period. One of the key impeding factor for the growth of the global immunohematology market is projected to be the high prices of the products. In addition to this, the general lack of awareness among the customers, specifically in the underdeveloped and developing nations about the availability and utility of these products is projected to slow down the market growth. Nonetheless, the increasing prevalence of target disorders and the rising demand from diagnostic laboratories and hospitals is expected to speed up the overall growth of the global immunohematology market over the coming years of the forecast period.

In terms of geographical regions, the global immunohematology market can be segmented into key regions such as North America, Asia Pacific, Europe, Latin America, and Middle East and Africa. Of these regions, North America market is expected to account for a vital share in the global market and is also expected to continue its dominance during the aforementioned forecast period. This growth is chiefly attributed to the increasing number of trauma centers and blood bank facilities in the region. The Asia Pacific market, on the other hand, is expected to show the most promising growth rate and present lucrative opportunities in the coming years.

Some of the key players in the global immunohematology market include names such as Grifols, Immucor, Bio-Rad Laboratories, Hologic Inc., and Beckman Coulter Inc. among others.

Get Sample Copy of this Report

https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1214